InvestorsHub Logo
Followers 6
Posts 753
Boards Moderated 0
Alias Born 08/06/2015

Re: rawsteel post# 15524

Wednesday, 02/12/2020 12:24:08 PM

Wednesday, February 12, 2020 12:24:08 PM

Post# of 16885
Canada (Knight's associates) has a sort of "socialized medine"----Which could boost Proneura use of Buprenorphine---but most likely has fewer "junkies" than USA.---sooo----the market there is ?????. If Molteni (European counterpart for TTNP) had some good news---it could boost the s/p----but, Europe has fewer "junkies"
---------------------------------------------------------------------------
5 million people misused prescription opioids in the U.S. in 2016, according to the 2016 National Survey on Drug Use and Health. (The total U.S. population in 2016 was approximately 323 million people.)
There are 1.3 million high-risk opioid users in the European Union, according to a report from the European Monitoring Centre for Drugs and Drug Addiction. (The total European population is approximately 511 million.)
---------------------------------------------------------------------------
If the sales are not good in the USA----You might expect sales to be even less "per capita" in The European Union & UK, & Canada.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News